Abstract
Hyperactivation of the PI3K/AKT/mTOR signaling pathway is common in cancer, and PI3K and mTOR act synergistically in promoting tumor growth, survival, and resistance to chemotherapy. Thus, combined targeting of PI3K and mTOR presents an opportunity for robust and synergistic anticancer efficacy. 17-Hydroxywortmannin (2a) analogues conjugated to rapamycin (3a) analogues via a prodrug linker are uniquely positioned for this approach. Our efforts led to the discovery of diester-linked conjugates that, upon in vivo hydrolysis, released two highly potent inhibitors. Conjugate 7c provided enhanced solubility relative to 3a and to an equivalent mixture of 3a and 9a and demonstrated profound activity in U87MG mouse xenografts, achieving an MED of 1.5 mg/kg, following weekly intravenous dosing. At 15 mg/kg, 7c completely inhibited the growth of HT29 tumors, whereas an equivalent mixture of the inhibitors was poorly tolerated. In the A498 renal tumor model, 7c exhibited superior efficacy over 3a or 9a when administered as a single agent or in combination with bevacizumab. Thus, we have uncovered a novel approach to target both PI3K and mTOR via hybrid inhibitors, leading to a broader and more robust anticancer efficacy.
References
Oct 1, 1984·The Journal of Antibiotics·C P EngC Vézina
Mar 1, 1996·Journal of Medicinal Chemistry·B H NormanC J Vlahos
Feb 13, 2001·International Journal of Pharmaceutics·P SimamoraS H Yalkowsky
Sep 25, 2002·Chemistry and Physics of Lipids·Yoshikatsu OgawaHiroaki Okuno
Jul 1, 2004·Organic & Biomolecular Chemistry·Peter WipfGarth Powis
Apr 23, 2005·Cancer Biology & Therapy·Ker YuJames Gibbons
Aug 17, 2005·Cancer Research·Shi-Yong SunFadlo R Khuri
Oct 14, 2005·Journal of Medicinal Chemistry·Richard Morphy, Zoran Rankovic
Oct 18, 2005·Molecular Cancer Therapeutics·Yijiang ShiAlan Lichtenstein
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen
Feb 17, 2006·Journal of Medicinal Chemistry·Tianmin ZhuArie Zask
Feb 23, 2007·Organic & Biomolecular Chemistry·Rebecca J M GossSteven J Moss
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Aug 2, 2007·Accounts of Chemical Research·Bernard Meunier
Jan 25, 2008·PLoS Medicine·Tim F CloughesyCharles L Sawyers
Feb 14, 2008·Journal of Medicinal Chemistry·Arie ZaskKer Yu
Jul 26, 2008·Lancet·Robert J MotzerUNKNOWN RECORD-1 Study Group
Sep 17, 2008·Cancer Research·Xuerong WangShi-Yong Sun
Sep 17, 2008·Oncogene·A Carracedo, P P Pandolfi
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo
Apr 23, 2009·Science Signaling·David A Guertin, David M Sabatini
Apr 24, 2009·Natural Product Reports·Edmund I Graziani
Citations
Dec 18, 2010·Journal of the American Chemical Society·Andrei V KarginovAlexander Deiters
Apr 23, 2011·Molecular Pharmaceutics·Wanyi TaiKun Cheng
Oct 12, 2013·Cell Death & Disease·S-A QuastJ Eberle
Nov 1, 2011·Nature Reviews. Drug Discovery·Don BenjaminMichael N Hall
May 25, 2011·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·E T PavlidisA K Sakantamis
Mar 16, 2012·Diagnostic Pathology·Sean KirbyKonstantin Shilo
Jan 14, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Andreas Müller-SchiffmannCarsten Korth
Aug 22, 2013·World Journal of Gastroenterology : WJG·Efstathios T Pavlidis, Theodoros E Pavlidis
Aug 24, 2012·Drug Target Insights·Upasana SarangiAmere Subbarao Sreedhar
Sep 28, 2013·Pharmaceutical Research·Wanyi TaiKun Cheng
Oct 21, 2011·Expert Opinion on Investigational Drugs·Bruno VincenziGiuseppe Tonini
Feb 5, 2016·Chemical & Pharmaceutical Bulletin·Lijun XieYuanrong Cheng
Dec 2, 2011·Journal of Ophthalmology·Jorge L Jacot, David Sherris
Apr 18, 2016·International Journal of Pharmaceutics·Jianjun HouYun Wu
Jun 16, 2015·Biochemical Pharmacology·Loana MussoFranco Zunino
Nov 13, 2007·BMC Cancer·Xinxin BuLixin Wei
Feb 7, 2006·Breast Cancer Research : BCR·Takashi KasukabeYoshio Honma
Sep 18, 2013·Acta Biochimica Et Biophysica Sinica·Xian XiaoXiang Zhang
Oct 1, 2010·Organic & Biomolecular Chemistry·Pietro MagroneSergio Riva
May 30, 2019·Organic & Biomolecular Chemistry·Ping-Gui LiLiang-Hua Zou
Dec 15, 2015·Beilstein Journal of Organic Chemistry·Ivan BassaniniSergio Riva
Sep 5, 2019·Scientific Reports·Yoshio KanoKenji Kawamura
Aug 21, 2012·Acta Crystallographica. Section E, Structure Reports Online·Lijun XieYuanrong Cheng
May 7, 2016·Archiv der Pharmazie·Lijun XieYuanrong Cheng
Jul 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ronald A NelsonMark E Welker
May 19, 2012·Acta Crystallographica. Section E, Structure Reports Online·Lijun XieYuanrong Cheng
Mar 15, 2021·Pharmacology Research & Perspectives·Geng-Ruei ChangTo-Pang Chen
Apr 29, 2021·Organic & Biomolecular Chemistry·Shalini SinghWahajul Haq
May 6, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marta SzumilakAndrzej Stanczak
May 21, 2010·Journal of Medicinal Chemistry·Kevin D Freeman-CookJoel Morris